Meeder Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,241
| Closed | -$130K | – | 2284 |
|
|
2020
Q3 | $130K | Buy |
+5,241
| New | +$130K | 0.01% | 710 |
|
|
2020
Q2 | – | Sell |
-2,699
| Closed | -$41K | – | 2543 |
|
|
2020
Q1 | $41K | Buy |
2,699
+1,076
| +66% | +$16.3K | ﹤0.01% | 992 |
|
|
2019
Q4 | $26K | Buy |
1,623
+580
| +56% | +$9.29K | ﹤0.01% | 1272 |
|
|
2019
Q3 | $14K | Buy |
+1,043
| New | +$14K | ﹤0.01% | 1428 |
|
|
2019
Q1 | – | Sell |
-614
| Closed | -$12K | – | 1900 |
|
|
2018
Q4 | $12K | Buy |
+614
| New | +$12K | ﹤0.01% | 1201 |
|
|
2018
Q1 | – | Sell |
-127
| Closed | -$5K | – | 1781 |
|
|
2017
Q4 | $5K | Buy |
+127
| New | +$5K | ﹤0.01% | 1329 |
|
|
2017
Q2 | – | Sell |
-505
| Closed | -$11K | – | 1919 |
|
|
2017
Q1 | $11K | Sell |
505
-254
| -33% | -$5.53K | ﹤0.01% | 845 |
|
|
2016
Q4 | $16K | Buy |
+759
| New | +$16K | ﹤0.01% | 687 |
|